Last updated: December 18, 2023
Sponsor: Zhenzhen Liu
Overall Status: Active - Recruiting
Phase
N/A
Condition
Lymphedema
Treatment
compression sleeves for upper limbs with a pressure level of 1 (15-20mmHg)
Clinical Study ID
NCT06095323
HNCH-BCRL001
Ages 18-70 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients aged 18 to 70 years old
- Breast cancer, unilateral,Patients undergoing axillary lymph node dissection
- Patients voluntarily joined the study and signed informed consent
Exclusion
Exclusion Criteria:
- arm swelling preoperatively, as assessed by bioimpedance spectroscopy (BIS) or Limbcircumference measurement
- any condition that hindered them from wearing a compression sleeve
- Patients with upper limb dysfunction before surgery, including shoulder and elbowjoint mobility disorders
- Patients with mental disorders, senile dementia, and cognitive impairments,were notable to complete a questionnaire independently
- Patients with bilateral breast cancer, recurrence, or metastasis to other organs.
Study Design
Total Participants: 480
Treatment Group(s): 1
Primary Treatment: compression sleeves for upper limbs with a pressure level of 1 (15-20mmHg)
Phase:
Study Start date:
October 16, 2023
Estimated Completion Date:
October 16, 2025
Study Description
Connect with a study center
Henan Cancer Hospital
Zhengzhou, Henan 450008
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.